Biopharma Companies Worldwide
Biopharma companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biopharma sector based on self-reported profile data. The directory currently holds 859 companies in this sector. The largest share of listings is based in United States (US). Related sectors on Enterprise League include Medical Equipment and Services, Laboratories, Genetics, First Aid, Health and Medical Products, Clinical Trials, Diabetes.
859 companies
United States (US) top country
Location
Category
Biopharma
List of Biopharma companies in All locations
859 companies
Sort by
NC Life Sciences Organization is a Durham, North Carolina-based nonprofit trade association dedicated to advancing the North Carolina life sciences industry.
We support a diverse ecosystem of companies, from startups to multinational corporations, fostering innovation and collaboration across the sector.
NCLifeSci delivers critical policy and advocacy leadership, drives workforce development programs, and provides invaluable industry connections, enabling our members to thrive in a global marketplace. We champion policies that encourage growth and support a strong life sciences workforce, ultimately contributing to economic opportunity and improved quality of life.
As the leading voice for North Carolina’s life sciences, we are committed to building a vibrant and successful industry for years to come.
We support a diverse ecosystem of companies, from startups to multinational corporations, fostering innovation and collaboration across the sector.
NCLifeSci delivers critical policy and advocacy leadership, drives workforce development programs, and provides invaluable industry connections, enabling our members to thrive in a global marketplace. We champion policies that encourage growth and support a strong life sciences workforce, ultimately contributing to economic opportunity and improved quality of life.
As the leading voice for North Carolina’s life sciences, we are committed to building a vibrant and successful industry for years to come.
Biopharma
Life Science
Biotechnology
Istari Oncology is a Durham, North Carolina-based biotechnology company developing innovative immunotherapy treatments for glioblastoma and other cancers.
Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.
Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.
Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
Founded in 2016 by leading researchers from Duke University Medical Center, Darell Bigner, MD, and Matthias Gromeier, MD, Istari Oncology is focused on harnessing the power of the immune system to combat these challenging diseases.
Our core expertise lies in developing novel immuno-oncology and immunotherapy platforms, utilizing virology, immunology, and monoclonal development to create targeted therapies. We are dedicated to advancing clinical-stage research and ultimately delivering life-changing treatments to patients battling cancer.
Istari Oncology is committed to pushing the boundaries of cancer treatment through rigorous scientific investigation and a patient-centric approach.
Biopharma
Life Science
Biotechnology
Duke Spark is a Durham, North Carolina-based AI initiative focused on medical imaging, operating under the Duke AI Health umbrella.
Spark’s mission is to develop and implement artificial intelligence algorithms for medical imaging, fostering collaboration between physicians and machine learning experts across various Duke departments, including Radiology, Surgery, Orthopaedic Surgery, and Computer Science.
This interdisciplinary initiative leverages significant investments from the Departments of Radiology and Surgery to drive cutting-edge research into surgical applications of imaging AI, ensuring the development of safe, effective, ethical, and equitable AI tools for healthcare.
Spark builds upon existing collaborative work across Duke, expanding its network of collaborators to address the widespread presence of medical imaging in nearly all medical specialties.
Spark’s mission is to develop and implement artificial intelligence algorithms for medical imaging, fostering collaboration between physicians and machine learning experts across various Duke departments, including Radiology, Surgery, Orthopaedic Surgery, and Computer Science.
This interdisciplinary initiative leverages significant investments from the Departments of Radiology and Surgery to drive cutting-edge research into surgical applications of imaging AI, ensuring the development of safe, effective, ethical, and equitable AI tools for healthcare.
Spark builds upon existing collaborative work across Duke, expanding its network of collaborators to address the widespread presence of medical imaging in nearly all medical specialties.
Biopharma
Life Science
Biotechnology
Belhaven Biopharma is a US-based biotechnology company specializing in the development of innovative dry powder nasal medicines for emergency treatment of severe allergic reactions and anaphylaxis.
We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.
Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.
Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
We are dedicated to improving global access to life-saving epinephrine treatments, particularly in underserved regions where traditional auto-injectors are unavailable or unreliable.
Our flagship product, Nasdepi®, represents a significant advancement in allergy care, offering a needle-free, heat-stable, and user-friendly alternative to existing epinephrine delivery methods. Nasdepi® is engineered for rapid absorption, simple administration, and long shelf life, addressing critical barriers to effective treatment.
Belhaven Biopharma’s mission is to empower individuals and families facing severe allergies with a reliable, accessible, and pain-free solution, ultimately reducing the risk of life-threatening anaphylaxis events worldwide.
Biopharma
Life Science
Biotechnology
PolarisQB is a Research and Development company based in RTP, North Carolina, pioneering the field of Quantum-Aided Drug Design (QuADD).
We leverage the power of quantum computing to revolutionize drug discovery, compressing the lead time for pre-clinical drug candidates from five years to just four months. This allows us to generate up to 100 drug blueprints annually, enabling rapid adaptation within the precision medicine market.
PolarisQB’s unique approach utilizes Quantum Annealing and Quantum Inspired Algorithms to explore a chemical space far exceeding the capabilities of traditional methods – over 10^30 chemical spaces compared to the limitations of conventional screening. We are dedicated to accelerating the development of novel therapeutics and personalized medicine solutions.
Founded in 2020, PolarisQB is rapidly establishing itself as a leader in computational chemistry, with a team of experts and a growing portfolio of intellectual property. We collaborate with pharmaceutical, biotech, and agricultural companies to unlock the potential of quantum computing for drug design.
We leverage the power of quantum computing to revolutionize drug discovery, compressing the lead time for pre-clinical drug candidates from five years to just four months. This allows us to generate up to 100 drug blueprints annually, enabling rapid adaptation within the precision medicine market.
PolarisQB’s unique approach utilizes Quantum Annealing and Quantum Inspired Algorithms to explore a chemical space far exceeding the capabilities of traditional methods – over 10^30 chemical spaces compared to the limitations of conventional screening. We are dedicated to accelerating the development of novel therapeutics and personalized medicine solutions.
Founded in 2020, PolarisQB is rapidly establishing itself as a leader in computational chemistry, with a team of experts and a growing portfolio of intellectual property. We collaborate with pharmaceutical, biotech, and agricultural companies to unlock the potential of quantum computing for drug design.
Biopharma
Life Science
Biotechnology
Aceragen is a Durham, North Carolina-based rare disease biopharmaceutical company focused on developing and commercializing innovative therapies for patients with debilitating conditions.
Following the merger with Idera Pharmaceuticals in 2022, Aceragen is dedicated to advancing its pipeline of novel treatments, particularly in the area of rare genetic diseases. We leverage a patient-centric approach, combining scientific expertise with a deep understanding of the challenges faced by patients and their families.
Aceragen’s core expertise lies in the development of targeted therapies, utilizing innovative technologies to address unmet medical needs. We are committed to improving the lives of patients and their families through the discovery and delivery of transformative medicines. Our team combines decades of experience in drug development, manufacturing, and commercialization, ensuring a robust pathway to market for our promising therapies. We operate with a strong focus on ethical practices and patient well-being.
Following the merger with Idera Pharmaceuticals in 2022, Aceragen is dedicated to advancing its pipeline of novel treatments, particularly in the area of rare genetic diseases. We leverage a patient-centric approach, combining scientific expertise with a deep understanding of the challenges faced by patients and their families.
Aceragen’s core expertise lies in the development of targeted therapies, utilizing innovative technologies to address unmet medical needs. We are committed to improving the lives of patients and their families through the discovery and delivery of transformative medicines. Our team combines decades of experience in drug development, manufacturing, and commercialization, ensuring a robust pathway to market for our promising therapies. We operate with a strong focus on ethical practices and patient well-being.
Biopharma
Life Science
Biotechnology
Synbiotic Health is a Lincoln, Nebraska-based biotechnology company specializing in the research, development, and marketing of ecologically-advanced probiotics.
We leverage our proprietary IVS™ and IVE™ discovery platforms to pioneer a new category of Synergistic Synbiotics™ – carefully selected combinations of probiotics and prebiotics designed to fundamentally change the gut microbiome.
Synbiotic Health distinguishes itself through a deep understanding of the ecological framework within the gut, focusing on establishing and competing beneficial bacteria. Our science prioritizes documented health benefits, offering a superior approach to existing probiotic offerings. Founded in 2018, we’ve grown to a team of 13 dedicated scientists and experts, committed to improving human health through innovative microbiome solutions.
We are dedicated to advancing the science of gut health and delivering impactful, evidence-based products to consumers and healthcare professionals alike.
We leverage our proprietary IVS™ and IVE™ discovery platforms to pioneer a new category of Synergistic Synbiotics™ – carefully selected combinations of probiotics and prebiotics designed to fundamentally change the gut microbiome.
Synbiotic Health distinguishes itself through a deep understanding of the ecological framework within the gut, focusing on establishing and competing beneficial bacteria. Our science prioritizes documented health benefits, offering a superior approach to existing probiotic offerings. Founded in 2018, we’ve grown to a team of 13 dedicated scientists and experts, committed to improving human health through innovative microbiome solutions.
We are dedicated to advancing the science of gut health and delivering impactful, evidence-based products to consumers and healthcare professionals alike.
Biopharma
Life Science
Biotechnology
Free to Feed is a Durham, North Carolina-based medical technology company dedicated to supporting breastfeeding mothers navigating infant food allergies.
We provide science-backed solutions to help families understand and manage infant food reactivity, offering a trusted alternative to blind elimination diets or relying solely on formula.
Free to Feed™ combines rigorous research with compassionate support, empowering parents with personalized plans and expert guidance. Our innovative allergen detection system, developed by a team of experienced scientists and healthcare professionals, provides valuable insights into breast milk composition, helping mothers make informed feeding decisions.
Founded in 2018 by Dr. Trill Paullin, PhD, Free to Feed™ is committed to advancing maternal-infant health through evidence-based innovation and a dedication to improving the lives of families facing these challenges.
We provide science-backed solutions to help families understand and manage infant food reactivity, offering a trusted alternative to blind elimination diets or relying solely on formula.
Free to Feed™ combines rigorous research with compassionate support, empowering parents with personalized plans and expert guidance. Our innovative allergen detection system, developed by a team of experienced scientists and healthcare professionals, provides valuable insights into breast milk composition, helping mothers make informed feeding decisions.
Founded in 2018 by Dr. Trill Paullin, PhD, Free to Feed™ is committed to advancing maternal-infant health through evidence-based innovation and a dedication to improving the lives of families facing these challenges.
Biopharma
Life Science
Biotechnology
CytexOrtho is a clinical-stage medical device company based in Durham, North Carolina, dedicated to revolutionizing orthopaedic treatment for cartilage repair.
We’re building on the pioneering tissue regeneration research of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos, leveraging their groundbreaking work to develop innovative implant solutions.
CytexOrtho’s approach focuses on regrowing cartilage and repairing damaged joints, offering a potential alternative to traditional hip replacements and addressing the growing market for osteoarthritis treatment. Our commitment to advancing patient care drives our research and development efforts, aiming to provide effective and lasting solutions for individuals suffering from joint pain.
Currently, our products are in development and not yet approved by the FDA or commercially available. We are focused on bringing this transformative technology to market, contingent upon regulatory approval.
We’re building on the pioneering tissue regeneration research of Dr. Farshid Guilak, Dr. Bradley Estes, and Dr. Frank Moutos, leveraging their groundbreaking work to develop innovative implant solutions.
CytexOrtho’s approach focuses on regrowing cartilage and repairing damaged joints, offering a potential alternative to traditional hip replacements and addressing the growing market for osteoarthritis treatment. Our commitment to advancing patient care drives our research and development efforts, aiming to provide effective and lasting solutions for individuals suffering from joint pain.
Currently, our products are in development and not yet approved by the FDA or commercially available. We are focused on bringing this transformative technology to market, contingent upon regulatory approval.
Biopharma
Life Science
Biotechnology
Innatrix is a Research Triangle Park, North Carolina-based agricultural biotechnology company dedicated to developing sustainable, eco-friendly biopesticides for currently untreatable crop diseases and pests.
We transform crop protection with rapid development of new products based on innovative, novel peptides and RNAi that are tailor-made to the needs of farmers. Our core technology, EvoStat, enables the evolution of these products to combat potential pest or pathogen resistance, offering a long-term and cost-effective solution for farmers.
Backed by a team of experienced scientists and significant venture capital funding, Innatrix is committed to empowering farmers to increase yields by at least 10% while achieving a return on investment exceeding 3x. We are focused on providing robust, sustainable solutions to the challenges of crop protection.
Currently, we are developing InnaLB™ for potato late blight, InnaNema™ for soybean cyst nematode, and InnaHLB™ for citrus greening.
We transform crop protection with rapid development of new products based on innovative, novel peptides and RNAi that are tailor-made to the needs of farmers. Our core technology, EvoStat, enables the evolution of these products to combat potential pest or pathogen resistance, offering a long-term and cost-effective solution for farmers.
Backed by a team of experienced scientists and significant venture capital funding, Innatrix is committed to empowering farmers to increase yields by at least 10% while achieving a return on investment exceeding 3x. We are focused on providing robust, sustainable solutions to the challenges of crop protection.
Currently, we are developing InnaLB™ for potato late blight, InnaNema™ for soybean cyst nematode, and InnaHLB™ for citrus greening.
Biopharma
Life Science
Biotechnology
Aer Therapeutics is a clinical-stage biopharmaceutical company based in Research Triangle Park, North Carolina, focused on developing innovative therapies for muco-obstructive lung diseases.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
We are dedicated to addressing a significant unmet need in the treatment of COPD and asthma, where mucus plugs frequently block airways, leading to reduced lung function and diminished quality of life.
AER-01, our lead therapeutic candidate, represents a novel approach – the first therapy designed to liquify mucus plugs by cleaving the chemical bonds that thicken mucus, effectively opening airways and restoring airflow.
Developed from groundbreaking research at UCSF, UCD, and Trinity College Dublin, and supported by over $18M in NIH grant funding, Aer Therapeutics is committed to transforming respiratory care and empowering patients to breathe freely. AER-01 is the first inhaled therapy developed to clear mucus blockages, helping to break the cycle of inflammation and restore the freedom to breathe.
Biopharma
Life Science
Biotechnology
Mass Spec Lab is a US-based analytical laboratory specializing in accurate mass spectrometry testing and analysis for the medical device, pharmaceutical, biotechnology, and food industries.
We provide comprehensive solutions for identifying and quantifying constituents and contaminants in substances and raw materials, supporting critical stages of product development and regulatory compliance.
Mass Spec Lab distinguishes itself through its commitment to utilizing state-of-the-art instrumentation and expert methodologies, ensuring timely, accurate, and targeted data for our clients. We offer a range of services including Leachables & Extractables testing, Targeted Screening Analysis, Structural Elucidation, Fingerprinting & Equivalence Testing, and Stability Testing.
Founded in 2014, Mass Spec Lab is a division of InVision Biomedical Group, dedicated to providing custom analytical services to the ophthalmic biomedical device sector and beyond.
We provide comprehensive solutions for identifying and quantifying constituents and contaminants in substances and raw materials, supporting critical stages of product development and regulatory compliance.
Mass Spec Lab distinguishes itself through its commitment to utilizing state-of-the-art instrumentation and expert methodologies, ensuring timely, accurate, and targeted data for our clients. We offer a range of services including Leachables & Extractables testing, Targeted Screening Analysis, Structural Elucidation, Fingerprinting & Equivalence Testing, and Stability Testing.
Founded in 2014, Mass Spec Lab is a division of InVision Biomedical Group, dedicated to providing custom analytical services to the ophthalmic biomedical device sector and beyond.
Biopharma
Life Science
Biotechnology
Rare Cancer Research Foundation is a Durham, North Carolina-based 501(c)3 nonprofit organization dedicated to curing rare cancers. We accelerate research and deploy promising therapies through patient-powered collaboration.
Our flagship initiative, Pattern.org, empowers patients to advocate for their care and directly impact cancer research, providing personalized data and treatment options.
Rare Cancer Research Foundation distinguishes itself by focusing on patient-centric research, building the tools and infrastructure to enable patients to drive research and researchers to advance treatment development. We are committed to transforming the landscape of rare cancer care through innovation and collaboration. Pattern.org and the Genomic Sequencing program are key components of our mission.
Our flagship initiative, Pattern.org, empowers patients to advocate for their care and directly impact cancer research, providing personalized data and treatment options.
Rare Cancer Research Foundation distinguishes itself by focusing on patient-centric research, building the tools and infrastructure to enable patients to drive research and researchers to advance treatment development. We are committed to transforming the landscape of rare cancer care through innovation and collaboration. Pattern.org and the Genomic Sequencing program are key components of our mission.
Biopharma
Life Science
Biotechnology
Novabiosis, Inc is a leading provider of isolated human primary cells and biological materials, based in Durham, North Carolina.
We specialize in supplying researchers with ethically sourced, non-transplantable human organs and tissues, obtained through a unique network of partnerships with 31 of the 55 CMS-regulated Organ Procurement Organizations (OPOs). This allows us to offer unparalleled access to both healthy and diseased samples, including internal organs, skin, cerebrospinal fluid (CSF), synovial fluid, and processed or snap-frozen tissues.
Novabiosis transforms complex biological material into ready-to-use research solutions, utilizing our expert cell isolation team to produce high-viability primary cells – cryopreserved and rigorously quality-controlled to ensure reproducible, early-stage research. Our services support advancements in cell biology, hepatocyte research, and more.
Founded in 2021 and currently employing 8 staff, Novabiosis is dedicated to expanding the precious gift of organ donation by minimizing discard and accelerating scientific discovery.
We specialize in supplying researchers with ethically sourced, non-transplantable human organs and tissues, obtained through a unique network of partnerships with 31 of the 55 CMS-regulated Organ Procurement Organizations (OPOs). This allows us to offer unparalleled access to both healthy and diseased samples, including internal organs, skin, cerebrospinal fluid (CSF), synovial fluid, and processed or snap-frozen tissues.
Novabiosis transforms complex biological material into ready-to-use research solutions, utilizing our expert cell isolation team to produce high-viability primary cells – cryopreserved and rigorously quality-controlled to ensure reproducible, early-stage research. Our services support advancements in cell biology, hepatocyte research, and more.
Founded in 2021 and currently employing 8 staff, Novabiosis is dedicated to expanding the precious gift of organ donation by minimizing discard and accelerating scientific discovery.
Biopharma
Life Science
Biotechnology
QuantaBricks is an AI-driven molecular discovery platform headquartered in New Jersey, empowering research teams with accessible and powerful computational chemistry tools.
We provide a revolutionary solution for drug discovery, enabling scientists to accelerate their research and development processes. Our platform utilizes artificial intelligence to streamline complex molecular simulations, dramatically reducing the time and resources required for traditional CADD (Computer-Aided Drug Design).
QuantaBricks offers a free AI transformation evaluation for drug discovery teams, demonstrating the potential of our technology. We are committed to democratizing access to advanced molecular modeling, fostering innovation and driving breakthroughs across the biotechnology and pharmaceutical industries.
With a team of experienced scientists and engineers, QuantaBricks is dedicated to pushing the boundaries of what’s possible in molecular discovery, helping researchers unlock new treatments and therapies.
We provide a revolutionary solution for drug discovery, enabling scientists to accelerate their research and development processes. Our platform utilizes artificial intelligence to streamline complex molecular simulations, dramatically reducing the time and resources required for traditional CADD (Computer-Aided Drug Design).
QuantaBricks offers a free AI transformation evaluation for drug discovery teams, demonstrating the potential of our technology. We are committed to democratizing access to advanced molecular modeling, fostering innovation and driving breakthroughs across the biotechnology and pharmaceutical industries.
With a team of experienced scientists and engineers, QuantaBricks is dedicated to pushing the boundaries of what’s possible in molecular discovery, helping researchers unlock new treatments and therapies.
Biopharma
Life Science
Biotechnology
B3 Quality Consulting, LLC is a Durham, North Carolina-based GXP consulting firm specializing in Right-Sized Quality™ solutions for life sciences companies.
We help early-stage biotech, pharmaceutical, and GxP service provider organizations build and maintain quality systems that are appropriately scaled to their needs and stage of development. Our focus is on providing flexible, senior-level quality expertise without the expense of a full-time head of quality.
At B3 Quality, we understand that many companies, particularly those in their early stages, don’t require a full-time quality leader. Instead, they need strategic quality leadership that can plan, direct, and conduct quality activities tailored to their specific phase. We offer fractional quality leadership, QMS builds, and GxP consulting to ensure you’re compliant and focused on innovation.
Our approach, Right-Sized Quality™, ensures you get the expertise you need when you need it, so you can stay compliant and focused on innovation. We’ve helped organizations like Blake’s and Mike’s companies build robust quality systems, and we’re committed to helping you do the same.
We help early-stage biotech, pharmaceutical, and GxP service provider organizations build and maintain quality systems that are appropriately scaled to their needs and stage of development. Our focus is on providing flexible, senior-level quality expertise without the expense of a full-time head of quality.
At B3 Quality, we understand that many companies, particularly those in their early stages, don’t require a full-time quality leader. Instead, they need strategic quality leadership that can plan, direct, and conduct quality activities tailored to their specific phase. We offer fractional quality leadership, QMS builds, and GxP consulting to ensure you’re compliant and focused on innovation.
Our approach, Right-Sized Quality™, ensures you get the expertise you need when you need it, so you can stay compliant and focused on innovation. We’ve helped organizations like Blake’s and Mike’s companies build robust quality systems, and we’re committed to helping you do the same.
Biopharma
Life Science
Biotechnology
Resilient Biotics is a Durham, North Carolina-based biotechnology company pioneering microbiome-based therapeutics for respiratory diseases in both human and animal health.
We are harnessing the power of advanced microbiome genomics and data science to develop innovative preventative and precision treatment strategies. Our proprietary Resilient Analytics platform combines high-resolution genomic analyses, machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains with immune activation and pathogen inhibition properties.
Resilient Biotics is dedicated to reducing reliance on antibiotics and improving patient outcomes through the targeted modulation of the respiratory microbiome. We are focused on creating a new class of therapeutics that leverages the inherent resilience of the microbiome to combat complex infectious diseases.
Founded in 2017, Resilient Biotics has secured significant venture funding and established strategic partnerships to accelerate the development of its pipeline. Our team, led by Rachelle Galvin and Christopher Belnap, brings together decades of experience in scientific innovation and drug development.
We are harnessing the power of advanced microbiome genomics and data science to develop innovative preventative and precision treatment strategies. Our proprietary Resilient Analytics platform combines high-resolution genomic analyses, machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains with immune activation and pathogen inhibition properties.
Resilient Biotics is dedicated to reducing reliance on antibiotics and improving patient outcomes through the targeted modulation of the respiratory microbiome. We are focused on creating a new class of therapeutics that leverages the inherent resilience of the microbiome to combat complex infectious diseases.
Founded in 2017, Resilient Biotics has secured significant venture funding and established strategic partnerships to accelerate the development of its pipeline. Our team, led by Rachelle Galvin and Christopher Belnap, brings together decades of experience in scientific innovation and drug development.
Biopharma
Life Science
Biotechnology
Global Stewardship Group is a Washington, D.C.-based non-profit organization dedicated to advancing plant biotechnology stewardship practices worldwide.
We support companies and organizations across the agricultural biotechnology sector, including seed producers, technology providers, and biotech associations, by offering comprehensive programs focused on transgene technology management, genome editing stewardship, and broader plant breeding innovation.
Our approach centers on flexibility, adaptability, and accessibility, ensuring that our programs integrate seamlessly into existing systems and provide valuable guidance to organizations of all sizes. We help ensure quality products reach the market, fostering trust with growers and consumers through robust stewardship practices.
Founded in 2008 as Excellence Through Stewardship, we’ve grown to encompass the Global Stewardship Group, reflecting our expanded scope of services and commitment to a more sustainable and responsible biotechnology landscape.
We support companies and organizations across the agricultural biotechnology sector, including seed producers, technology providers, and biotech associations, by offering comprehensive programs focused on transgene technology management, genome editing stewardship, and broader plant breeding innovation.
Our approach centers on flexibility, adaptability, and accessibility, ensuring that our programs integrate seamlessly into existing systems and provide valuable guidance to organizations of all sizes. We help ensure quality products reach the market, fostering trust with growers and consumers through robust stewardship practices.
Founded in 2008 as Excellence Through Stewardship, we’ve grown to encompass the Global Stewardship Group, reflecting our expanded scope of services and commitment to a more sustainable and responsible biotechnology landscape.
Biopharma
Life Science
Biotechnology
Bontera BioAg is a Dallas, Texas-based provider of microbial technologies, dedicated to enhancing agricultural practices and promoting sustainable soil health.
We specialize in developing and delivering innovative biological solutions for growers seeking to improve crop yield, quality, and overall profitability. Bontera’s approach centers on harnessing the power of naturally-occurring soil microbes – including Bacillus, Trichodermas, and Rhizobium – to create robust root development, increased nutrient availability, and enhanced plant health.
Our custom blend solutions and market-ready products are 100% organically derived, compatible with sustainable and organic growing practices, and represent a commitment to nurturing land health for future generations. We work with growers to tailor microbial blends to specific crop and soil needs, supporting a more resilient and productive agricultural ecosystem.
We specialize in developing and delivering innovative biological solutions for growers seeking to improve crop yield, quality, and overall profitability. Bontera’s approach centers on harnessing the power of naturally-occurring soil microbes – including Bacillus, Trichodermas, and Rhizobium – to create robust root development, increased nutrient availability, and enhanced plant health.
Our custom blend solutions and market-ready products are 100% organically derived, compatible with sustainable and organic growing practices, and represent a commitment to nurturing land health for future generations. We work with growers to tailor microbial blends to specific crop and soil needs, supporting a more resilient and productive agricultural ecosystem.
Biopharma
Life Science
Biotechnology
Claris Bio is a leading biopharmaceutical company based in Jersey City, New Jersey, dedicated to restoring corneal integrity and improving patient outcomes.
We are pioneering the development of innovative topical ocular biologic solutions, specifically dHGF, to address unmet needs in ophthalmology, particularly in conditions like Limbal Stem Cell Deficiency (LCSD) and neurotrophic keratopathy (NK).
Founded on the groundbreaking research of Dr. Reza Dana and Dr. Sunil Chauhan at the Massachusetts Eye and Ear Infirmary, Claris Bio combines scientific expertise with a seasoned leadership team – including Clarke Atwell, Susan Orr, Henry Rath, and Tomi Luan – to accelerate the translation of promising therapies into life-changing treatments. Our commitment to data-driven decision making and robust preclinical findings positions us at the forefront of corneal therapy.
We are not currently hiring.
We are pioneering the development of innovative topical ocular biologic solutions, specifically dHGF, to address unmet needs in ophthalmology, particularly in conditions like Limbal Stem Cell Deficiency (LCSD) and neurotrophic keratopathy (NK).
Founded on the groundbreaking research of Dr. Reza Dana and Dr. Sunil Chauhan at the Massachusetts Eye and Ear Infirmary, Claris Bio combines scientific expertise with a seasoned leadership team – including Clarke Atwell, Susan Orr, Henry Rath, and Tomi Luan – to accelerate the translation of promising therapies into life-changing treatments. Our commitment to data-driven decision making and robust preclinical findings positions us at the forefront of corneal therapy.
We are not currently hiring.
Biopharma
Life Science
Biotechnology
BioAesthetics is a US-based biotechnology company specializing in tissue-engineered solutions for breast reconstruction. Founded in 2015 as a Tulane University spin-out, we develop innovative products to improve outcomes for patients undergoing mastectomies.
Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.
BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.
We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.
Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.
BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.
We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.
Biopharma
Life Science
Biotechnology
ELEXAN Scientific is a California-based microfluidics and microfabrication supply company, dedicated to simplifying access to high-performance fluidic technologies.
We provide a comprehensive selection of fittings, connectors, tubing, and flow control equipment, ensuring researchers and engineers have the essential components for their experiments and manufacturing processes. Our commitment to rapid order fulfillment from our Irvine facility allows you to focus on innovation, while our diverse product range caters to a wide spectrum of applications.
ELEXAN Scientific is your trusted partner for reliable, high-quality microfluidic solutions, supporting advancements across biotechnology research and beyond. We strive to streamline your sourcing experience, empowering you to push the boundaries of discovery.
We provide a comprehensive selection of fittings, connectors, tubing, and flow control equipment, ensuring researchers and engineers have the essential components for their experiments and manufacturing processes. Our commitment to rapid order fulfillment from our Irvine facility allows you to focus on innovation, while our diverse product range caters to a wide spectrum of applications.
ELEXAN Scientific is your trusted partner for reliable, high-quality microfluidic solutions, supporting advancements across biotechnology research and beyond. We strive to streamline your sourcing experience, empowering you to push the boundaries of discovery.
Biopharma
Life Science
Biotechnology
Canary Advisors is a Durham, North Carolina-based patient advocacy and clinical trial support services firm dedicated to aligning clinical development programs with patient needs.
We partner with biopharma, nonprofit, and regulatory stakeholders to understand disease impacts, unmet needs, and patient preferences. Our approach centers on providing tailored solutions, including early-stage patient advocacy, regulatory and legislative support, access and reimbursement planning, and patient experience data collection.
Founded in 2022 by Jenn McNary, Richie Kahn, and Jen Shumsky, Canary Advisors combines decades of experience in rare disease clinical development, patient advocacy, and regulatory affairs. We’re committed to translating research into actionable insights that truly benefit patients and their families. We’ve been recognized for our responsiveness, impact, and innovative strategies, consistently prioritizing the patient voice in drug and device development.
Our team provides a range of services, from clinical trial concierge to patient-focused drug development consultancy, ensuring that every project is strategically aligned with corporate objectives and patient needs.
We partner with biopharma, nonprofit, and regulatory stakeholders to understand disease impacts, unmet needs, and patient preferences. Our approach centers on providing tailored solutions, including early-stage patient advocacy, regulatory and legislative support, access and reimbursement planning, and patient experience data collection.
Founded in 2022 by Jenn McNary, Richie Kahn, and Jen Shumsky, Canary Advisors combines decades of experience in rare disease clinical development, patient advocacy, and regulatory affairs. We’re committed to translating research into actionable insights that truly benefit patients and their families. We’ve been recognized for our responsiveness, impact, and innovative strategies, consistently prioritizing the patient voice in drug and device development.
Our team provides a range of services, from clinical trial concierge to patient-focused drug development consultancy, ensuring that every project is strategically aligned with corporate objectives and patient needs.
Biopharma
Life Science
Biotechnology
Syntr Health Technologies is an Irvine, California-based biotechnology company pioneering the field of regenerative medicine. We’ve developed the SyntrFuge System, the world’s only automated microfat processing system, enabling clinicians to harness the body’s own fat tissue for natural rejuvenation and healing.
Our FDA-cleared system simplifies and standardizes fat transfer procedures, offering a consistent and affordable alternative to traditional fillers. We’re dedicated to advancing innovative solutions for aesthetics, wound care, and future medical applications, including orthopedic and gastrointestinal surgery.
Syntr’s automated process dramatically improves fat cell viability and repeatability, leading to superior patient outcomes and a streamlined workflow for practitioners. We are currently enrolling patients in a randomized control trial to investigate using autologous microsized fat tissue in the healing of diabetic foot ulcers.
Join our growing network of clinician partners and unlock the potential of microfat.
Our FDA-cleared system simplifies and standardizes fat transfer procedures, offering a consistent and affordable alternative to traditional fillers. We’re dedicated to advancing innovative solutions for aesthetics, wound care, and future medical applications, including orthopedic and gastrointestinal surgery.
Syntr’s automated process dramatically improves fat cell viability and repeatability, leading to superior patient outcomes and a streamlined workflow for practitioners. We are currently enrolling patients in a randomized control trial to investigate using autologous microsized fat tissue in the healing of diabetic foot ulcers.
Join our growing network of clinician partners and unlock the potential of microfat.
Biopharma
Life Science
Biotechnology
IMMvention Therapeutix, Inc is a US-based biotechnology company specializing in the discovery and development of novel small molecule inhibitors targeting Bach1, a key transcription factor.
We are focused on creating transformative therapies for patients suffering from a range of debilitating diseases, including sickle cell disease (SCD), renal diseases, cardiometabolic diseases, and neurodegenerative diseases. Our research and development efforts are centered around oral medications, offering a more accessible treatment option for patients globally.
IMMvention Therapeutix is a venture-funded company dedicated to advancing innovative treatments and improving patient outcomes. We leverage cutting-edge research in molecular biology to address unmet medical needs and bring impactful therapies to market. Our team combines deep scientific expertise with a commitment to patient-centric drug development.
Founded in 2017 and currently employing 13 individuals, IMMvention Therapeutix is rapidly progressing its pipeline of potential therapies, demonstrating significant promise in addressing complex diseases.
We are focused on creating transformative therapies for patients suffering from a range of debilitating diseases, including sickle cell disease (SCD), renal diseases, cardiometabolic diseases, and neurodegenerative diseases. Our research and development efforts are centered around oral medications, offering a more accessible treatment option for patients globally.
IMMvention Therapeutix is a venture-funded company dedicated to advancing innovative treatments and improving patient outcomes. We leverage cutting-edge research in molecular biology to address unmet medical needs and bring impactful therapies to market. Our team combines deep scientific expertise with a commitment to patient-centric drug development.
Founded in 2017 and currently employing 13 individuals, IMMvention Therapeutix is rapidly progressing its pipeline of potential therapies, demonstrating significant promise in addressing complex diseases.
Biopharma
Life Science
Biotechnology
EndoCyclic Therapeutics is an Irvine, California-based biopharmaceutical company pioneering innovative, non-hormonal therapeutics and diagnostics for women’s health and oncology.
We are dedicated to revolutionizing endometriosis care with the development of the first potential disease-modifying therapeutic, ENDO-205, designed to eliminate lesions and associated symptoms – addressing a condition that affects over 190 million women globally.
Our precision peptide technology enables targeted delivery, reducing off-target side effects and offering a non-invasive alternative to traditional diagnostic methods. We are also advancing an investigational imaging diagnostic agent, FemLUNA, for endometriosis and other cancers, representing a new era of precision treatment.
EndoCyclic Therapeutics is committed to transforming patient lives through groundbreaking solutions in women’s health and oncology.
We are dedicated to revolutionizing endometriosis care with the development of the first potential disease-modifying therapeutic, ENDO-205, designed to eliminate lesions and associated symptoms – addressing a condition that affects over 190 million women globally.
Our precision peptide technology enables targeted delivery, reducing off-target side effects and offering a non-invasive alternative to traditional diagnostic methods. We are also advancing an investigational imaging diagnostic agent, FemLUNA, for endometriosis and other cancers, representing a new era of precision treatment.
EndoCyclic Therapeutics is committed to transforming patient lives through groundbreaking solutions in women’s health and oncology.
Biopharma
Life Science
Biotechnology
Alera Labs is a fast, low-cost contract analytical testing laboratory based in Durham, North Carolina, serving the pharmaceutical, biotech, medical device, and agricultural industries.
We specialize in providing rapid turnaround times and cost-effective analytical solutions to support early-stage drug development and research. Alera Labs was founded in 2010 to address the needs of smaller companies seeking responsive and budget-friendly analytical services.
Our core expertise lies in method development, validation, impurity identification, biomarker analysis, and bioanalytical testing, utilizing advanced instrumentation such as GC-MS, LC-MS/MS, and ICP-MS. We are committed to delivering high-quality data and accelerating our clients’ projects.
We specialize in providing rapid turnaround times and cost-effective analytical solutions to support early-stage drug development and research. Alera Labs was founded in 2010 to address the needs of smaller companies seeking responsive and budget-friendly analytical services.
Our core expertise lies in method development, validation, impurity identification, biomarker analysis, and bioanalytical testing, utilizing advanced instrumentation such as GC-MS, LC-MS/MS, and ICP-MS. We are committed to delivering high-quality data and accelerating our clients’ projects.
Biopharma
Life Science
Biotechnology
Vindara is a US-based domain brokerage specializing in premium domain names, operating since 2005. We provide a surprisingly human shopping experience and secure transactions for millions of domains. Our mission is to connect individuals and businesses with the perfect brandable names, offering competitive prices and exceptional service. We’ve helped thousands of people find the ideal domain, building a vast portfolio of over 4 million domains and adding new ones daily. We prioritize customer satisfaction, offering a 30-day money-back guarantee and secure payment options, including payment plans.
We focus on providing a seamless and trustworthy domain registration process. Our commitment to excellent service and a wide selection of premium domains makes us a leading source for brandable names.
HugeDomains offers a 100% satisfaction guarantee on every domain name we sell. We also provide WhoIs Privacy Protection to safeguard your personal information. Our team is dedicated to helping you find the perfect domain to elevate your online presence.
We focus on providing a seamless and trustworthy domain registration process. Our commitment to excellent service and a wide selection of premium domains makes us a leading source for brandable names.
HugeDomains offers a 100% satisfaction guarantee on every domain name we sell. We also provide WhoIs Privacy Protection to safeguard your personal information. Our team is dedicated to helping you find the perfect domain to elevate your online presence.
Biopharma
Life Science
Biotechnology
IngateyGen LLC is a Durham, North Carolina-based agricultural biotechnology company dedicated to developing allergen-free peanut varieties. We leverage cutting-edge techniques in genomics, proteomics, and plant tissue culture to create improved peanuts with enhanced safety and nutritional value, addressing the significant health and economic impact of peanut allergies. Our work directly supports the food value chain, aiming to provide quality products to market while minimizing the risk of severe allergic reactions. We are a portfolio company of AgTechInventures, furthering our commitment to innovation in AgBiotechnology.
Peanut allergies affect over 2.5% of children in the U.S., triggering life-threatening reactions and imposing a substantial economic burden on families and the healthcare system. Schools routinely prohibit peanut products to mitigate these risks, and the airline industry has implemented similar precautions.
IngateyGen’s approach centers on utilizing CRISPR and gene editing technologies to modify peanut genetics, resulting in hypoallergenic or allergen-reduced peanuts. Furthermore, we are pioneering the development of Self-Stabilizing Natural Peanut Butter and high-protein peanuts as plant-based meat alternatives, responding to growing consumer demand for healthy and sustainable protein sources. Our team, led by Dr. Hortense Dodo and Dr. Koffi Konan, combines expertise in plant biotechnology, immunology, and food science to drive our mission forward.
Peanut allergies affect over 2.5% of children in the U.S., triggering life-threatening reactions and imposing a substantial economic burden on families and the healthcare system. Schools routinely prohibit peanut products to mitigate these risks, and the airline industry has implemented similar precautions.
IngateyGen’s approach centers on utilizing CRISPR and gene editing technologies to modify peanut genetics, resulting in hypoallergenic or allergen-reduced peanuts. Furthermore, we are pioneering the development of Self-Stabilizing Natural Peanut Butter and high-protein peanuts as plant-based meat alternatives, responding to growing consumer demand for healthy and sustainable protein sources. Our team, led by Dr. Hortense Dodo and Dr. Koffi Konan, combines expertise in plant biotechnology, immunology, and food science to drive our mission forward.
Biopharma
Life Science
Biotechnology
inSoma Bio is a Durham, North Carolina-based biotechnology company pioneering bio-inspired solutions for reconstructive plastic surgery.
At inSoma Bio, we leverage nature’s own designs to develop unique products for reconstructive plastic surgery. Our product enables surgeons to use a person’s own tissue instead of synthetic implants and fillers to improve procedures like breast and facial reconstruction.
Our technology, Fractomer Biomatrix, is based on protein sequences naturally found in the human body. These bio-inspired Fractomers provide support, shape, and biointegration for co-injected cells or tissues, featuring a thermal switch that activates at body temperature and are designed at the genetic level.
Founded by a team of biomedical engineers and clinicians with 60 years of combined domain expertise, inSoma is dedicated to improving patient outcomes through innovative tissue regeneration.
At inSoma Bio, we leverage nature’s own designs to develop unique products for reconstructive plastic surgery. Our product enables surgeons to use a person’s own tissue instead of synthetic implants and fillers to improve procedures like breast and facial reconstruction.
Our technology, Fractomer Biomatrix, is based on protein sequences naturally found in the human body. These bio-inspired Fractomers provide support, shape, and biointegration for co-injected cells or tissues, featuring a thermal switch that activates at body temperature and are designed at the genetic level.
Founded by a team of biomedical engineers and clinicians with 60 years of combined domain expertise, inSoma is dedicated to improving patient outcomes through innovative tissue regeneration.
Biopharma
Life Science
Biotechnology
Micoy Therapeutics is a Jersey City, New Jersey-based biotechnology company pioneering therapies to block harmful autoantibodies and strengthen immune defenses.
We are dedicated to revolutionizing the treatment of life-threatening viral infections and cancer by addressing a previously overlooked vulnerability: the presence of harmful autoantibodies that impair the immune system’s ability to combat viruses or respond effectively to anticancer therapy.
Micoy Therapeutics develops targeted therapies and companion diagnostics, including the NeuroLume™ rapid test for Folate Receptor Autoantibodies (FRAAs) and decoy biologics to neutralize Type I Interferon Autoantibodies. Our innovative approach combines immunology, protein engineering, and diagnostic innovation to detect and neutralize these autoantibodies early, restoring immune balance and protecting individuals from a wide range of viral threats.
Led by a team of experts in drug discovery, immunology, and translational medicine, Micoy Therapeutics is building a platform for immune health across the lifespan, revealing how autoantibodies shape human health and creating practical solutions to restore balance and resilience.
We are dedicated to revolutionizing the treatment of life-threatening viral infections and cancer by addressing a previously overlooked vulnerability: the presence of harmful autoantibodies that impair the immune system’s ability to combat viruses or respond effectively to anticancer therapy.
Micoy Therapeutics develops targeted therapies and companion diagnostics, including the NeuroLume™ rapid test for Folate Receptor Autoantibodies (FRAAs) and decoy biologics to neutralize Type I Interferon Autoantibodies. Our innovative approach combines immunology, protein engineering, and diagnostic innovation to detect and neutralize these autoantibodies early, restoring immune balance and protecting individuals from a wide range of viral threats.
Led by a team of experts in drug discovery, immunology, and translational medicine, Micoy Therapeutics is building a platform for immune health across the lifespan, revealing how autoantibodies shape human health and creating practical solutions to restore balance and resilience.
Biopharma
Life Science
Biotechnology
AchieveBio is a leading search firm specializing in recruitment for the biotechnology and life science industries, based in Lincoln, Nebraska.
We connect top-tier professionals – including executive management, sales and marketing experts, and technical personnel – with innovative companies and established leaders across North America.
AchieveBio distinguishes itself through a consultative approach, deeply understanding client needs to deliver exceptional candidates. With 15 years of experience and an extensive network, we focus on identifying and securing those top contributors who drive business success.
Founded in 2008, AchieveBio is committed to ethical recruitment practices and building lasting relationships with both clients and candidates, ultimately helping organizations achieve their strategic goals.
We connect top-tier professionals – including executive management, sales and marketing experts, and technical personnel – with innovative companies and established leaders across North America.
AchieveBio distinguishes itself through a consultative approach, deeply understanding client needs to deliver exceptional candidates. With 15 years of experience and an extensive network, we focus on identifying and securing those top contributors who drive business success.
Founded in 2008, AchieveBio is committed to ethical recruitment practices and building lasting relationships with both clients and candidates, ultimately helping organizations achieve their strategic goals.
Biopharma
Life Science
Biotechnology
Qalitex Laboratories is a leading ISO 17025 accredited laboratory providing comprehensive chemistry and microbiology testing services for the dietary supplements, cosmetics, and food industries, based in Irvine and San Diego, California.
We specialize in supporting brands with rapid turnaround times – delivering signed Certificates of Analysis within 48-72 hours – ensuring product safety, efficacy, and compliance. Our state-of-the-art facilities and experienced team offer a full suite of analytical and microbiological testing, including HPLC, ICP-MS, and USP / compliance testing.
Qalitex distinguishes itself through direct scientist access, transparent pricing, and a commitment to startup-friendly service, making us the trusted partner for brands seeking rigorous testing and reliable results. We serve over 50 brands worldwide, with a focus on speed, precision, and clear communication.
We specialize in supporting brands with rapid turnaround times – delivering signed Certificates of Analysis within 48-72 hours – ensuring product safety, efficacy, and compliance. Our state-of-the-art facilities and experienced team offer a full suite of analytical and microbiological testing, including HPLC, ICP-MS, and USP / compliance testing.
Qalitex distinguishes itself through direct scientist access, transparent pricing, and a commitment to startup-friendly service, making us the trusted partner for brands seeking rigorous testing and reliable results. We serve over 50 brands worldwide, with a focus on speed, precision, and clear communication.
Biopharma
Life Science
Biotechnology
Marine Bio-Technologies Center of Innovation is a North Carolina-based nonprofit organization dedicated to fostering the growth of marine biotechnology. Established in 2012, MBCOI serves as a crucial nexus for marine science and biotechnology research, driving innovation and commercialization within the region.
We connect researchers, businesses, and policymakers to translate groundbreaking discoveries into tangible products and services. Our work spans a diverse range of applications, including pharmaceuticals, nutraceuticals, cosmeceuticals, and aquaculture, contributing to North Carolina’s economic development and global competitiveness.
MBCOI’s unique approach combines a regional focus with international collaboration, facilitating the exchange of knowledge and resources. We are committed to advancing marine biotechnology and creating a sustainable future through scientific innovation. We support a wide array of research areas, including genomics, marine natural products, algae, and waste remediation.
We connect researchers, businesses, and policymakers to translate groundbreaking discoveries into tangible products and services. Our work spans a diverse range of applications, including pharmaceuticals, nutraceuticals, cosmeceuticals, and aquaculture, contributing to North Carolina’s economic development and global competitiveness.
MBCOI’s unique approach combines a regional focus with international collaboration, facilitating the exchange of knowledge and resources. We are committed to advancing marine biotechnology and creating a sustainable future through scientific innovation. We support a wide array of research areas, including genomics, marine natural products, algae, and waste remediation.
Biopharma
Life Science
Biotechnology
Love Contracts is a Durham, North Carolina-based clinical strategic outsourcing solutions provider exclusively supporting small biotech, biopharma, and med devices companies.
We understand the unique challenges faced by these emerging life sciences organizations – lean teams, aggressive timelines, and high-stakes trials – and offer a refreshingly professional approach to outsourcing.
As a results-driven global provider, Love Contracts, now Nova Outsourcing Management, leverages deep, hands-on experience from both the sponsor and CRO sides of the industry to deliver strategic outsourcing solutions, win-win negotiations, and strong vendor partnerships.
Led by Julia Love and Murtza Naseem, Nova helps companies maximize their investments and accelerate their clinical portfolios through innovative outsourcing strategies.
We understand the unique challenges faced by these emerging life sciences organizations – lean teams, aggressive timelines, and high-stakes trials – and offer a refreshingly professional approach to outsourcing.
As a results-driven global provider, Love Contracts, now Nova Outsourcing Management, leverages deep, hands-on experience from both the sponsor and CRO sides of the industry to deliver strategic outsourcing solutions, win-win negotiations, and strong vendor partnerships.
Led by Julia Love and Murtza Naseem, Nova helps companies maximize their investments and accelerate their clinical portfolios through innovative outsourcing strategies.
Biopharma
Life Science
Biotechnology
Vitality Robotics is a Durham, North Carolina-based robotics and machine learning integration company, specializing in developing no-code custom AI models.
We empower scientific teams and laboratories worldwide to automate workflows and accelerate breakthroughs in both biomedical and business applications.
Vitality Robotics leverages its expertise in AI, robotics, and software development – including our Labtools.AI platform – to deliver tailored solutions that save time and money, ultimately driving impactful and transformative outcomes.
As an AWS services partner, we provide comprehensive support and guidance to our clients, ensuring seamless integration and maximizing the benefits of AI-driven automation.
We empower scientific teams and laboratories worldwide to automate workflows and accelerate breakthroughs in both biomedical and business applications.
Vitality Robotics leverages its expertise in AI, robotics, and software development – including our Labtools.AI platform – to deliver tailored solutions that save time and money, ultimately driving impactful and transformative outcomes.
As an AWS services partner, we provide comprehensive support and guidance to our clients, ensuring seamless integration and maximizing the benefits of AI-driven automation.
Biopharma
Life Science
Biotechnology
BioLabs North Carolina is a premier biotech coworking facility located in downtown Durham, North Carolina, providing fully equipped, wet lab space for life science companies.
We cater to ambitious startup companies in the biotechnology research sector, offering a collaborative environment with top-of-the-line research equipment. Our goal is to accelerate resident companies’ milestones, reducing capital expenditure through shared resources and expert support.
BioLabs North Carolina simplifies the complexities of early-stage biotech development by offering a streamlined, supportive ecosystem. We are dedicated to fostering innovation and growth within the life sciences industry, connecting entrepreneurs with the tools and network they need to succeed.
Established in 2017, BioLabs North Carolina currently supports a team of 3 professionals and is strategically positioned to become a leading hub for biotech startups in the region.
We cater to ambitious startup companies in the biotechnology research sector, offering a collaborative environment with top-of-the-line research equipment. Our goal is to accelerate resident companies’ milestones, reducing capital expenditure through shared resources and expert support.
BioLabs North Carolina simplifies the complexities of early-stage biotech development by offering a streamlined, supportive ecosystem. We are dedicated to fostering innovation and growth within the life sciences industry, connecting entrepreneurs with the tools and network they need to succeed.
Established in 2017, BioLabs North Carolina currently supports a team of 3 professionals and is strategically positioned to become a leading hub for biotech startups in the region.
Biopharma
Life Science
Biotechnology
Vivacelle Bio is a late-stage biopharma company based in Kansas City, Missouri, developing life-saving treatments for shock and trauma. Leveraging our pioneering and patented phospholipid nanoparticle technology, we address the urgent global crisis of sepsis and acute hemorrhage.
Millions of lives are lost each year due to sepsis, a leading cause of death worldwide, often stemming from relative or absolute hypovolemia. Our lead product, VBI-S, utilizes a unique mechanism to redistribute nitric oxide, elevating blood pressure in patients who are refractory to standard fluid therapy.
This innovative approach represents a new paradigm in critical care, offering a potential lifeline for patients facing devastating outcomes. We’ve secured backing from venture capital, the US Department of Defense, and the National Institutes of Health, and are currently enrolling patients in a Phase III clinical trial. VBI-S aims to transform treatment outcomes and save countless lives.
We are committed to advancing this technology and bringing a much-needed solution to patients and healthcare providers worldwide.
Millions of lives are lost each year due to sepsis, a leading cause of death worldwide, often stemming from relative or absolute hypovolemia. Our lead product, VBI-S, utilizes a unique mechanism to redistribute nitric oxide, elevating blood pressure in patients who are refractory to standard fluid therapy.
This innovative approach represents a new paradigm in critical care, offering a potential lifeline for patients facing devastating outcomes. We’ve secured backing from venture capital, the US Department of Defense, and the National Institutes of Health, and are currently enrolling patients in a Phase III clinical trial. VBI-S aims to transform treatment outcomes and save countless lives.
We are committed to advancing this technology and bringing a much-needed solution to patients and healthcare providers worldwide.
Biopharma
Life Science
Biotechnology
CBio is a Tampa, Florida-based systems engineering company pioneering solutions to help drug manufacturers bring cell and viral vector gene therapies to patients when they need it most.
CBio builds quality testing equipment and kits using novel separation science techniques, machine vision, and edge computing to ensure the life saving treatments will work as expected and are safe for patients to receive.
What sets CBio apart is our patented technology, which is able to identify microbial contamination and other quality issues such as detection of empty virus particles much faster than todays gold standard methods reducing weeks of testing time to within 48 hours.
Our transformative solution helps address critical issues affecting bio-manufacturing and quality testing to allow release of the powerful life saving treatments to patients when they need it most. We focus on diseases where effective treatments exist but remain out of reach because of cost, manufacturing complexity, or supply constraints. The science is solved. The access isn't.
CBio builds quality testing equipment and kits using novel separation science techniques, machine vision, and edge computing to ensure the life saving treatments will work as expected and are safe for patients to receive.
What sets CBio apart is our patented technology, which is able to identify microbial contamination and other quality issues such as detection of empty virus particles much faster than todays gold standard methods reducing weeks of testing time to within 48 hours.
Our transformative solution helps address critical issues affecting bio-manufacturing and quality testing to allow release of the powerful life saving treatments to patients when they need it most. We focus on diseases where effective treatments exist but remain out of reach because of cost, manufacturing complexity, or supply constraints. The science is solved. The access isn't.
Biopharma
Life Science
Biotechnology
Hudson Therapeutics, US Subsidiary of Shaperon is a clinical-stage biotechnology company based in Durham, North Carolina, focused on developing innovative drugs for inflammatory and immunological diseases.
Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr. Shawn Y. Seong, Hudson Therapeutics, Inc. leverages a strategic approach to enhance therapeutic potential.
Our core strategy involves in-licensing promising assets, adding value through innovative development, and ultimately out-licensing them to maximize their commercialization. We are dedicated to enriching patients’ quality of life through advancements in anti-inflammatory and immunology therapies.
Founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea, and led by Dr. Shawn Y. Seong, Hudson Therapeutics, Inc. leverages a strategic approach to enhance therapeutic potential.
Our core strategy involves in-licensing promising assets, adding value through innovative development, and ultimately out-licensing them to maximize their commercialization. We are dedicated to enriching patients’ quality of life through advancements in anti-inflammatory and immunology therapies.
Biopharma
Life Science
Biotechnology
Grid Therapeutics is a Durham, North Carolina-based biotechnology company focused on developing targeted immunotherapy for cancer.
We are pioneering the first human-derived antibody, designated GT103, to treat refractory non-small cell lung cancer (NSCLC). Our approach leverages exceptional outcomes observed in early lung cancer patients, isolating and engineering a novel antibody from patient B-cells using advanced molecular genomic techniques.
Grid Therapeutics is currently enrolling patients in a Phase 1 clinical trial, representing a significant step forward in personalized cancer treatment. We are dedicated to advancing innovative solutions for patients battling difficult-to-treat cancers.
Founded in 2014, Grid Therapeutics builds upon the groundbreaking research of Edward F. Patz, Jr. MD and his team at Duke University Medical Center, bringing decades of scientific expertise to the development of life-saving therapies.
We are pioneering the first human-derived antibody, designated GT103, to treat refractory non-small cell lung cancer (NSCLC). Our approach leverages exceptional outcomes observed in early lung cancer patients, isolating and engineering a novel antibody from patient B-cells using advanced molecular genomic techniques.
Grid Therapeutics is currently enrolling patients in a Phase 1 clinical trial, representing a significant step forward in personalized cancer treatment. We are dedicated to advancing innovative solutions for patients battling difficult-to-treat cancers.
Founded in 2014, Grid Therapeutics builds upon the groundbreaking research of Edward F. Patz, Jr. MD and his team at Duke University Medical Center, bringing decades of scientific expertise to the development of life-saving therapies.
Biopharma
Life Science
Biotechnology
Pulvinar Neuro is a Durham, North Carolina-based neurotechnology company specializing in innovative and affordable brain stimulation solutions for researchers.
We develop and manufacture the XCSITE 100, a leading tDCS/tACS research system, which is trusted by leading neuroscience labs across the United States. Our mission is to accelerate basic and translational neuroscience research by providing accessible and reliable tools.
Pulvinar Neuro is dedicated to supporting the advancement of neuroscience through continuous technological development and collaboration with the research community. We offer a range of products and services designed to meet the evolving needs of neuroscientists, fostering breakthroughs in understanding the brain.
Since launching the XCSITE 100 in 2016, we’ve grown to a team of 9, committed to pushing the boundaries of neurotechnology.
We develop and manufacture the XCSITE 100, a leading tDCS/tACS research system, which is trusted by leading neuroscience labs across the United States. Our mission is to accelerate basic and translational neuroscience research by providing accessible and reliable tools.
Pulvinar Neuro is dedicated to supporting the advancement of neuroscience through continuous technological development and collaboration with the research community. We offer a range of products and services designed to meet the evolving needs of neuroscientists, fostering breakthroughs in understanding the brain.
Since launching the XCSITE 100 in 2016, we’ve grown to a team of 9, committed to pushing the boundaries of neurotechnology.
Biopharma
Life Science
Biotechnology
NANO DISCOVERY, INC is an Orlando, Florida-based biotechnology company specializing in rapid blood tests for animal immune health. We develop, manufacture, and sell the D2Dx™ immunity test, a one-of-its-kind test that allows quick and accurate assessment of an animal’s immune status on the farm, on the animal side.
Our technology serves a diverse range of animal sectors, including livestock (cattle, sheep, goats, poultry, swine), companion animals (dogs and cats), and fish/shellfish.
D2Dx™ provides valuable insights for producers, farmers, and veterinarians, enabling informed decisions regarding animal care, nutrition, and treatment. Furthermore, our products are applicable to human and non-human primate research, supporting drug development and vaccine trials.
Founded in 2009, Nano Discovery Inc. is committed to advancing animal health through innovative diagnostic solutions.
Our technology serves a diverse range of animal sectors, including livestock (cattle, sheep, goats, poultry, swine), companion animals (dogs and cats), and fish/shellfish.
D2Dx™ provides valuable insights for producers, farmers, and veterinarians, enabling informed decisions regarding animal care, nutrition, and treatment. Furthermore, our products are applicable to human and non-human primate research, supporting drug development and vaccine trials.
Founded in 2009, Nano Discovery Inc. is committed to advancing animal health through innovative diagnostic solutions.
Biopharma
Life Science
Biotechnology
Tiamat Sciences Corp is a Durham, North Carolina-based plant-based platform and product life sciences company. We are revolutionizing reagent production for the pharmaceutical industry, empowering partners to create innovative therapies while simultaneously reducing material costs, accelerating development timelines, and minimizing environmental impact through a decarbonized supply chain.
Our core offering centers around a proprietary platform that dramatically simplifies and optimizes the creation of high-quality, plant-derived reagents. This allows pharmaceutical companies and biotech firms to focus on their core research and development efforts, rather than being constrained by complex and costly reagent sourcing.
Founded in 2019, Tiamat Sciences is committed to driving sustainable innovation in the life sciences sector. We leverage cutting-edge biotechnology and a deep understanding of plant-based chemistry to deliver a superior alternative to traditional reagent production methods. We are dedicated to supporting the next generation of pharmaceutical products and fostering a more environmentally responsible industry.Plant-based reagents, pharmaceutical industry, biotechnology, sustainable innovation
Our core offering centers around a proprietary platform that dramatically simplifies and optimizes the creation of high-quality, plant-derived reagents. This allows pharmaceutical companies and biotech firms to focus on their core research and development efforts, rather than being constrained by complex and costly reagent sourcing.
Founded in 2019, Tiamat Sciences is committed to driving sustainable innovation in the life sciences sector. We leverage cutting-edge biotechnology and a deep understanding of plant-based chemistry to deliver a superior alternative to traditional reagent production methods. We are dedicated to supporting the next generation of pharmaceutical products and fostering a more environmentally responsible industry.Plant-based reagents, pharmaceutical industry, biotechnology, sustainable innovation
Biopharma
Life Science
Biotechnology
Myodenovo is a Durham, North Carolina-based biotechnology company pioneering the development of sustainable meat production through advanced bioreactor technology.
We cultivate the highest quality, most tender meats – including prized cuts like filet mignon – without relying on animal agriculture. Our approach mirrors nature’s most efficient processes, utilizing bioreactors and cell scaffolds inspired by greenhouses and plant growth.
Myodenovo’s innovative technology offers a delicious and ethical alternative to traditional meat production, catering to discerning meat aficionados and contributing to a more sustainable food future. We are committed to providing a premium culinary experience while minimizing environmental impact.
We cultivate the highest quality, most tender meats – including prized cuts like filet mignon – without relying on animal agriculture. Our approach mirrors nature’s most efficient processes, utilizing bioreactors and cell scaffolds inspired by greenhouses and plant growth.
Myodenovo’s innovative technology offers a delicious and ethical alternative to traditional meat production, catering to discerning meat aficionados and contributing to a more sustainable food future. We are committed to providing a premium culinary experience while minimizing environmental impact.
Biopharma
Life Science
Biotechnology
Okogen, Inc is a US-based biotechnology company developing innovative therapeutics for ophthalmic infectious diseases, specifically focusing on acute infectious conjunctivitis.
We are dedicated to addressing a significant unmet need in the treatment of pink eye, a common condition affecting millions annually. Our lead product candidate, OKG-0303, is a ‘one-stop shop’ treatment for both bacterial and viral conjunctivitis, offering a comprehensive solution for healthcare professionals.
Okogen’s approach centers on a proprietary formulation combining antiviral, ocular decongestant, and antibacterial agents, aiming to simplify treatment and improve patient outcomes. With a growing market of $4.2 billion annually for conjunctivitis treatments, Okogen is positioned to become a leader in this space.
Currently, we are in Phase 2B clinical trials and have recently secured $3.3M in funding to advance our clinical program. Our team, led by CEO Joshua H. Moriarty and Chief Medical Officer David A. Hollander, brings extensive experience in ophthalmic pharmaceutical development.
We are dedicated to addressing a significant unmet need in the treatment of pink eye, a common condition affecting millions annually. Our lead product candidate, OKG-0303, is a ‘one-stop shop’ treatment for both bacterial and viral conjunctivitis, offering a comprehensive solution for healthcare professionals.
Okogen’s approach centers on a proprietary formulation combining antiviral, ocular decongestant, and antibacterial agents, aiming to simplify treatment and improve patient outcomes. With a growing market of $4.2 billion annually for conjunctivitis treatments, Okogen is positioned to become a leader in this space.
Currently, we are in Phase 2B clinical trials and have recently secured $3.3M in funding to advance our clinical program. Our team, led by CEO Joshua H. Moriarty and Chief Medical Officer David A. Hollander, brings extensive experience in ophthalmic pharmaceutical development.
Biopharma
Life Science
Biotechnology
DataPrudence is an Irvine, California-based AI-powered bioinformatics company specializing in accelerating research discoveries. We provide end-to-end solutions for processing and analyzing next-generation sequencing, clinical, and biomedical datasets, leveraging cutting-edge machine learning and GPU-accelerated pipelines.
Our team combines bioinformatics expertise with advanced computing and AI to deliver transformative insights for life science research. We offer a comprehensive suite of services, including Bulk RNA-Seq Data Analysis & Gene Expression Profiling, Single-Cell & Multi-Omics Data Analysis, and Interactive Data Visualization & Custom Applications.
DataPrudence is recognized for its domain experts, AI-driven insights, and commitment to high-impact scientific research. We’ve contributed to key studies published in JCI Insight and JACC: Basic to Translational Science, demonstrating our ability to accelerate discoveries and provide measurable results. We’re proud to be a Carboctet Brand.
Our team combines bioinformatics expertise with advanced computing and AI to deliver transformative insights for life science research. We offer a comprehensive suite of services, including Bulk RNA-Seq Data Analysis & Gene Expression Profiling, Single-Cell & Multi-Omics Data Analysis, and Interactive Data Visualization & Custom Applications.
DataPrudence is recognized for its domain experts, AI-driven insights, and commitment to high-impact scientific research. We’ve contributed to key studies published in JCI Insight and JACC: Basic to Translational Science, demonstrating our ability to accelerate discoveries and provide measurable results. We’re proud to be a Carboctet Brand.
Biopharma
Life Science
Biotechnology
SLBST Pharma is a US-based biotechnology company developing innovative therapies for endometriosis, a debilitating condition affecting millions of women.
We are focused on transforming endometriosis treatment by targeting the underlying inflammatory mechanisms driving the disease. Our lead candidate, entering Phase 2b trials, is a re-purposed version of the well-established immunomodulator hydroxychloroquine (HCQ), offering a potential first-line treatment option with a strong safety profile.
SLBST Pharma holds issued patents protecting this novel indication and is committed to delivering a cost-effective and impactful solution for patients suffering from this challenging disease. We are dedicated to advancing women’s health through targeted research and development.
We are focused on transforming endometriosis treatment by targeting the underlying inflammatory mechanisms driving the disease. Our lead candidate, entering Phase 2b trials, is a re-purposed version of the well-established immunomodulator hydroxychloroquine (HCQ), offering a potential first-line treatment option with a strong safety profile.
SLBST Pharma holds issued patents protecting this novel indication and is committed to delivering a cost-effective and impactful solution for patients suffering from this challenging disease. We are dedicated to advancing women’s health through targeted research and development.
Biopharma
Life Science
Biotechnology
NeuroQure is a California-based biotechnology company pioneering early autism risk detection. We’re dedicated to changing lives through groundbreaking innovations, starting with the ASD Insight™ autism risk test – a simple skin test that provides insights into autism risk from birth.
Our mission is to empower parents and healthcare providers with the information they need to take meaningful steps during the critical early stages of development.
ASD Insight™ utilizes a revolutionary cellular biomarker detection technology, built on 8 years of robust academic research, offering a key factor supporting immediate action to learning about access to impactful interventions in children who are on the autism spectrum.
We’ve helped thousands of families gain clarity and access to vital support, and continue to expand our reach through strategic partnerships and ongoing research.
Our mission is to empower parents and healthcare providers with the information they need to take meaningful steps during the critical early stages of development.
ASD Insight™ utilizes a revolutionary cellular biomarker detection technology, built on 8 years of robust academic research, offering a key factor supporting immediate action to learning about access to impactful interventions in children who are on the autism spectrum.
We’ve helped thousands of families gain clarity and access to vital support, and continue to expand our reach through strategic partnerships and ongoing research.
Biopharma
Life Science
Biotechnology
Growth Curve Bio is a Durham, North Carolina-based precision fermentation CDMO/CMO, specializing in benchtop and pilot-scale services.
We support clients across a diverse range of industries – including alternative protein, biopharma, biofuels, and personal care – accelerating their development timelines with a focus on quality, velocity, and simplicity.
Growth Curve Bio provides critical infrastructure and expert support to companies navigating the complexities of precision fermentation, from early-stage research to scale-up. We help you streamline your processes and achieve faster, more reliable results.
Founded in 2023, our team of experienced scientists and engineers is dedicated to empowering innovation in the bioeconomy. We are committed to providing flexible, fee-for-service solutions tailored to your specific needs.
We support clients across a diverse range of industries – including alternative protein, biopharma, biofuels, and personal care – accelerating their development timelines with a focus on quality, velocity, and simplicity.
Growth Curve Bio provides critical infrastructure and expert support to companies navigating the complexities of precision fermentation, from early-stage research to scale-up. We help you streamline your processes and achieve faster, more reliable results.
Founded in 2023, our team of experienced scientists and engineers is dedicated to empowering innovation in the bioeconomy. We are committed to providing flexible, fee-for-service solutions tailored to your specific needs.
Biopharma
Life Science
Biotechnology
Company Name | Location | Category | Employees | Accuracy | Website | |
|---|---|---|---|---|---|---|
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@nclifesci.org | https://www.nclifesci.org/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@istarioncology.com | http://istarioncology.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | aihealth@duke.edu | https://aihealth.duke.edu/spark/ | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@belhavenbio.com | http://www.belhavenbio.com | ||
RTP, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@polarisqb.com | http://www.polarisqb.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aceragen.com | https://www.aceragen.com/ | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | sales@synbiotichealth.com | http://synbiotichealth.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@freetofeed.com | http://www.freetofeed.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cytexortho.com | https://cytexortho.com | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@innatrix.com | https://www.innatrix.com/ | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aertherapeutics.com | http://aertherapeutics.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@massspeclab.com | http://www.massspeclab.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@rarecancer.org | http://rarecancer.org | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | support@novabiosis.com | https://novabiosis.com/ | ||
Newark, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@quantabricks.xyz | https://www.quantabricks.xyz/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@b3quality.com | https://b3quality.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@resilientbiotics.com | http://www.resilientbiotics.com | ||
Washington, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@excellencethroughstewardship.org | http://excellencethroughstewardship.org | ||
Dallas, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@bontera.com | http://www.bontera.com | ||
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@clarisbio.com | https://clarisbio.com/ | ||
Research Triangle Park, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | contact@bio-aesthetics.com | http://www.bio-aesthetics.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@elexansci.com | http://elexansci.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@canaryadvisorsllc.com | http://www.canaryadvisorsllc.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@syntrhealth.com | http://www.syntrhealth.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@immventionthera.com | http://www.immventionthera.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@endocyclictherapeutics.com | http://www.endocyclictherapeutics.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@aleralabs.com | http://www.aleralabs.com | ||
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@vindara.com | http://www.vindara.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@ingateygen.com | http://www.ingateygen.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@insomabio.com | https://insomabio.com/ | ||
Jersey City, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@micoytherapeutics.com | https://www.micoytherapeutics.com/ | ||
Lincoln, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@achievebio.com | http://achievebio.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@qalitex.com | http://www.qalitex.com | ||
Wilmington, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@mbcoi.net | http://www.mbcoi.net | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | julia.love@novaoutsourcingmgmt.com | http://www.novaoutsourcingmgmt.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | hello@vitalityrobotics.com | https://www.vitalityrobotics.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@biolabs.io | https://www.biolabs.io/location/north-carolina | ||
Chicago, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@vivacellebio.com | http://www.VivacelleBio.com | ||
Tampa, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@cbio.io | https://www.cbio.io | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | peoples@hudsontherapeutics.com | http://HudsonTherapeutics.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@gridtherapeutics.com | http://www.gridtherapeutics.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@pulvinarneuro.com | https://www.pulvinarneuro.com/ | ||
Orlando, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@nanodiscoveryinc.com | http://www.nanodiscoveryinc.com/ | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@tiamat-sciences.com | http://www.tiamat-sciences.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@myodenovo.com | http://myodenovo.com | ||
Plano, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@okogen.com | http://www.okogen.com | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@dataprudence.com | https://www.dataprudence.com | ||
St Petersburg, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | admin@slbstpharma.com | https://www.slbstpharma.com/ | ||
Irvine, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@neuroqure.com | http://www.neuroqure.com | ||
Durham, United States (US) | Health and Medical +1 Health and Medical, Science and Engineering | 2-10 | info@growthcurvebio.com | http://www.growthcurvebio.com |
50/859 results
Frequently asked questions
FAQ updated November 2025
What is Enterprise League?
Enterprise League is a business platform built for the doers, small businesses and startups who want to get seen, get leads, and grow.We help you showcase your company, connect directly with potential clients and partners, and get valuable insights into your performance, all without the middlemen or the fluff. Whether you're a team of 2 or 200, Enterprise League puts you on equal ground with the big players.
How can my business benefit from joining Enterprise League?
You get visibility, leads, and control, all in one place. Joining Enterprise League puts your business in front of thousands of verified companies. List your services, connect with decision-makers, and see real-time data on who’s visiting your profile.It’s a streamlined way to grow your presence, build partnerships, and stop relying on outdated directories or cold outreach.
What are the key features of Enterprise League?
Enterprise League gives you tools to grow faster: • Custom Profiles:Boos your visibility with a standout business profile. • Smart search: Get found by clients looking for your exact services. • Real analytics: See who's visiting, what's working and where you rank. • Direct messaging: Skip the cold emails and chat direct with prospects. • Reviews insights: Showcase real reviews and let AI highlight what matters. • Zero-fee marketplace: List and find products or services for free.
How does the company verification process work?
Get verified for the price of a coffee $0 Verified companies appear higher in search, build trust faster, and unlock an extra features. One badge. More business.
Can I try Enterprise League for free?
Absolutely. Our Free Plan is built for small businesses. You get profile visibility, marketplace access, and business directory use, free. Want more reach and features? Upgrade when you’re ready. No pressure.
How does the Interactive Business Directory work?
It’s like Google, but only for serious businesses. Search by location, size, or sector. Visit company profiles, send a message, or download insights. It’s built for real B2B decisions, not noise.
How can I download business insights?
Need competitor or market data? We’ve got it, and yes, you can download it. With our Business Insights Download feature, you can export detailed company and industry data in CSV format, including decision-makers, background info, and more. It’s perfect for sales targeting, market research, or just getting smarter about your next move.
What is the Referral Program?
Invite a business friend. You both get rewarded. Refer another company and when they join, you both get 1 month of Premium — free. It’s our way of growing the community with good people.
How does the Reviews feature work?
Show off your best reviews, without lifting a finger. We pull your reviews from Google, Facebook, Trustpilot and more. Then our AI highlights the most important insights. You just sit back and shine.
What plans are available?
Three simple plans: Free Plan: Get started with a verified profile, search access, and the ability to add products and services. Premium: More reach, more leads, deeper analytics. Ultimate: All the bells and whistles, including a dedicated growth partner.
How can my company win an award?
We highlight the best of the best, and that could be you. We run 50+ startup award categories every year. Apply for free. Winners get recognition, visibility, and bragging rights.